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SHORT REPORT
Diagnostic value of the Rotterdam-CAMCOG in post-stroke
dementia
I de Koning, F van Kooten, P J Koudstaal, D W J Dippel
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
J Neurol Neurosurg Psychiatry 2005;76:263–265. doi: 10.1136/jnnp.2004.039511
Background and Objective: Specific screening tests to detect
post-stroke dementia are lacking. We recently reported that
an adaptation of the Cambridge Cognitive Examination
(CAMCOG), the Rotterdam-CAMCOG, had excellent sensi-
tivity and specificity for detecting post-stroke dementia. In this
study, we externally validated the diagnostic accuracy of the
R-CAMCOG in a new, representative cohort of stroke
patients.
Methods: The R-CAMCOG and an extensive neuropsycho-
logical examination were administered, independently of
each other, in 121 patients aged 55 and over with a stroke in
the preceding three to nine months. The gold standard
diagnosis of dementia was based on the results of the
extensive neuropsychological examination, clinical presenta-
tion, and information from a close relative, as well as DSM-IV
criteria.
Results: Of the 121 patients, 35 had dementia (29%). The
diagnostic accuracy at the pre-specified cut-off point of 33/
34 was established through receiver operating characteristic
(ROC) analyses (sensitivity 66%, specificity 94%). At a cut-off
point of 36/37 sensitivity would be 83% and specificity 78%.
Conclusion: The R-CAMCOG is a useful screening tool for
post-stroke dementia in a clinical setting.
U
ntil recently, no specific screening tests were available
for the detection of post-stroke dementia. This led to an
increased risk of misclassification in screening proce-
dures, as most screening tests are aimed at cortical distur-
bances, consistent with Alzheimer’s disease. We recently
reported that the Cambridge Cognitive Examination
(CAMCOG) is suitable for screening in post-stroke dementia,1
but it has a major drawback, namely the relatively lengthy
administration time of approximately 25 minutes. We there-
fore developed a modified version of the CAMCOG, the
Rotterdam-CAMCOG, which is easy to administer, taking
approximately 10 minutes.2 This is an important aspect of
stroke management because of the high caseload: approxi-
mately a quarter of all hospitalised stroke patients will have
dementia.3–5 A preliminary analysis of the diagnostic value of
the R-CAMCOG on the dataset used to develop the test
suggested that the high sensitivity and specificity were
preserved after adaptation.2 However, external validation
and assessment of reliability in a different series of patients
with stroke was necessary to determine the value of the R-
CAMCOG as a screening instrument for dementia in patients
with a recent stroke. In the present study, we prospectively
assessed the diagnostic accuracy of the R-CAMCOG in a new
representative cohort of 121 patients with stroke.
METHODS
Patients
Between October 2000 and July 2002 patients with stroke
from various centres in the region (Rotterdam-Rijnmond)
were enrolled in the study. The patients had to be 55 years or
older and have had a transient ischaemic attack (TIA) with
neurological signs on examination, ischaemic stroke, or intra-
cerebral haemorrhage in the preceding three to nine months.
The stroke had to be confirmed by a neurologist, and
neuroimaging had to be available. Patients were excluded
when a reliable assessment of dementia could not be made
because of aphasia (that is, a score less than 3 on the Aphasia
Severity Rating Scale from the Boston Diagnostic Aphasia
Examination),6 severe sensory handicaps (for example, deaf-
ness or blindness), persistent impairment in consciousness,
severe psychiatric symptoms, or insufficient command of the
Dutch language. Additional criteria for exclusion were a TIA
without neurological signs on examination, concomitant
primary cerebral disorder or severe comorbidity with a short
life expectancy. Informed consent was obtained from all
patients or from close relatives in case of impaired judge-
ment. The local medical ethics committee approved the study.
Procedure
In each centre, consecutive eligible patients were asked (or
their families) to participate in the study. At inclusion,
detailed information about cardiovascular risk factors, stroke
characteristics, and premorbid status was obtained from the
patient’s files. Premorbid cognitive functioning was assessed
by interviewing a close relative and the score on the Blessed
Dementia Scale7 to establish prestroke cognitive decline or
dementia. Education was categorised into levels from 1 =
less than six years of primary education to 7 = academic
schooling.8 Between three and nine months after the onset of
stroke two trained research assistants administered either the
R-CAMCOG or an extended neuropsychological examination,
independently of each other. We used the same neuropsy-
chological test battery as in our previous study.1 The research
assistant who administered the R-CAMCOG was unaware of
the neuropsychological test results, and vice versa. The ‘‘gold
standard’’ diagnosis of dementia was based on the results of
the extensive neuropsychological examination, clinical pre-
sentation, and information from a close relative. When a
patient was not able to perform a test due to a motor handi-
cap, we used the results of the non-motor counterpart(s).
In some patients not all tests could be administered due to
cognitive disturbances and these patients were only included
when a reliable judgement of cognitive functioning could be
made. The final judgement of cognitive functioning was
made by a diagnostic panel (neurologist and neuropsychol-
ogist). DSM-IV criteria were used for the assessment of
dementia,9 which was further subclassified according to the
research criteria of the NINDS-AIREN international work-
shop,10 where possible Alzheimer’s disease (AD) and cere-
brovascular disease (AD and CVD) is a potential diagnosis
next to probable and possible vascular dementia (VaD).
Abbreviations: CAMCOG, Cambridge Cognitive Examination; R-
CAMCOG, Rotterdam-CAMCOG; TIA, transient ischaemic attack
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Statistics
The clinical characteristics of the patients with and without
dementia were compared using the Student’s t test and the x2
test when appropriate. The diagnostic accuracy (sensitivity
and specificity) of the R-CAMCOG was estimated with
receiver operating characteristic (ROC) analyses at a pre-
specified cut-off point of 33/34.2 All statistical analyses were
carried out with Stata software.11
We estimated that a sample size of 150, with a prevalence
of dementia of 20% would provide sufficiently accurate
sensitivity and specificity (standard error of the mean: 0.05
and 0.03, respectively), however, for logistic reasons, the total
number of patients included was lower (121 v 150). Before
analysing the data we noted that the frequency of patients
with dementia was higher than expected before the study
(29% v 20%). We therefore assumed that the precision (and
standard error) of our estimates would not be affected by the
smaller sample size.
Of 130 patients considered eligible by the treating phy-
sician, nine had to be excluded: two patients were younger
than 55 years, two patients had a history of psychiatric
illness, in two (nursing home) patients the diagnosis of
stroke could not be confirmed, and in three patients informed
consent was withdrawn after initial consent.
The baseline characteristics of the study population are
shown in table 1 (mean age 70 years; approximately 40%
women). Patients with dementia were seven years older than
the patients without dementia (p,0.001). There was no
significant difference in the level of education. None of the
patients who had had a TIA had dementia. Six patients had
dementia before their most recent stroke (AD, 2; VaD, 4). The
total score and subtest scores on the R-CAMCOG were
significantly lower in the demented group.
The diagnostic accuracy and test characteristics of the R-
CAMCOG were determined at the prespecified cut-off value
of 33/34, which suggested the highest diagnostic accuracy in
a previous study (fig 1). The sensitivity at this cut-off value
was 66% (95% confidence interval (CI) 50% to 82%) and the
specificity was 94% (95% CI 89% to 99%), with a positive
predictive value of 82%.
DISCUSSION
In the present study we aimed to confirm the diagnostic
accuracy of the R-CAMCOG in a representative stroke
population. The findings of this study are different from
our previous study in which the R-CAMCOG was developed.
Table 1 Demographic and clinical characteristics of the study population
Patients with
dementia
(n = 35)
Patients without
dementia
(n = 86)
Total
(n = 121) p value
Age (SD) 74.9 (8.8) 68.1 (8.3) 70 (9.0) ,0.001
Years of education (SD) 8.9 (4.1) 9.6 (3.1) 9.4 (3.4) 0.17
Level of education
Primary school 17 (48%) 27 (31%) 44 (37%)
Vocational education 10 (29%) 28 (33%) 38 (31%)
Secondary education 8 (23%) 31 (36%) 39 (32%) 0.18
No. of women 13 (37%) 33 (38%) 46 (38%) 0.9
Type of stroke
TIA 0 (0%) 25 (29%) 25 (21%)
Infarction 27 (77%) 50 (58%) 77 (63%)
Intracerebral haemorrhage 8 (23%) 11 (13%) 19 (16%) 0.001
Site of stroke
Infratentorial 1 (3%) 9 (11%) 10 (8%)
Right hemisphere 23 (66%) 39 (46%) 62 (52%)
Left hemisphere 11 (31%) 36 (43%) 47 (40%) 0.11
Computed tomography (CT) variables
Main findings (n = 120)
Normal CT 3 (9%) 29 (34%) 32 (26%)
Recent infarct only 15 (43%) 27 (32%) 42 (35%)
Old infarct only 4 (11%) 10 (12%) 14 (12%)
Single intracerebral haemorrhage 7 (20%) 7 (8%) 14 (12%)
Multiple lesions 6 (17%) 12 (14%) 18 (15%) 0.05
Recent infarct type (n = 58)
Large (end zone and/or large deep) 17 (81%) 21 (57%) 38 (66%)
Lacunar 4 (19%) 16 (43%) 20 (34%) 0.06
Leukoaraiosis (n = 120) 19 (54%) 23 (27%) 42 (35%) 0.004
Cerebral atrophy (n = 120) 9 (26%) 14 (16%) 23 (19%) 0.24
R-CAMCOG subscores (SD)
Orientation (maximum=8) 5.5 (2.1) 7.6 (0.6) 7.0 (1.6) ,0.001
Memory (maximum=25) 14.1 (4.5) 20.1 (2.7) 18.4 (4.3) ,0.001
Abstraction (maximum=8) 4.7 (2.2) 6.3 (1.5) 5.8 (1.9) ,0.001
Perception (maximum=8) 4.5 (1.3) 6.1 (1.3) 5.7 (1.5) ,0.001
Total (maximum=49) 28.8 (8.2) 40.1 (4.1) 36.8 (7.6) ,0.001
Figure 1 Receiver operating characteristic analysis curve to determine
the diagnostic accuracy of R-CAMCOG in a prospective study.
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Not surprisingly, the sensitivity and specificity of the R-
CAMCOG was higher in the former study since it provided
the data used to construct the test. This can be attributed to
several types of optimism bias that come into play during the
selection and evaluation of predictors.12 In fact, this provided
the rationale for conducting the present study.
The clinical validity and usefulness of the R-CAMCOG
depend on its accuracy and ease of use. In this respect, a
limitation of this study was that we did not directly compare
the R-CAMCOG with the Mini Mental State Examination
(MMSE) or other tests. At the prespecified cut-off point, the
sensitivity of the R-CAMCOG was estimated at 66% (95% CI
50% to 82%). The MMSE’s sensitivity was 69% (95% CI 57%
to 81%) at the accepted cut-off value of 23/24 in our previous
study on vascular factors in dementia in a very similar stroke
population. The R-CAMCOG, however, has higher specificity
(94% v 84%).1
High specificity is of great importance, because the diag-
nostic workup in screen-positive patients is time consuming
for the patient and expensive. The moderate sensitivity at the
cut-off point of 33/34 may be a disadvantage in the light of
the recent development of new and experimental treatments
for post-stroke dementia. For these purposes it may be useful
to set the cut-off value higher, as is frequently done with
screening instruments in other studies. With a cut-off point
of 36/37 the sensitivity increases considerably to 83% (95% CI
71% to 95%), while the specificity is still acceptable (78%;
95% CI 70% to 86%). Further testing of R-CAMCOG positive
patients would yield a diagnosis of dementia in every second
patient, while one in every 20 R-CAMCOG negative patients
would have dementia ‘‘missed’’ initially.
For the present study, patients with moderate or severe
aphasia were excluded because the R-CAMCOG was not
considered as a suitable screening instrument in this sub-
group. A screening tool for patients with moderate to severe
aphasia would have additional value, but may not be easily
realised.
Furthermore, a recent study by Graham et al13 showed that
executive functioning plays an important role in a particular
subgroup of vascular dementia—that is, subcortical vascular
dementia. It remains unclear whether the lack of executive
items in the R-CAMCOG is a drawback when screening for
post-stroke dementia. The clinical picture of patients with
stroke as well as restraints due to the direct consequences of a
stroke, such as hemiparesis or mild aphasia, may place other
demands on a screening instrument.
The impetus for developing a feasible and valid instrument
to screen for post-stroke dementia stemmed from the relative
incompetence of the existing screening instruments for this
purpose. Our study results suggest that the R-CAMCOG
may be of limited use as a screening instrument in a large
population, but is a useful instrument for screening in post-
stroke dementia in a clinical setting.
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